Facebook Linkedin Soundcloud Twitter Vimeo Xing
Home Tags PD-1/PD-L1

Tag: PD-1/PD-L1

BYON4228 Enhances Anti-tumor Immunity In Vitro

ADC Review | Editorial Team
CD47, an immunoglobulin also called integrin-associated protein (IAP), is a tumor-associated antigen (TAA) expressed on the surface of normal, healthy, hematopoietic stem cells (HSC)...

Preclinical Data Suggests Synergy between STRO-002 and Immune Checkpoint Inhibitors, Resulting...

Peter Hofland
Data presented at the 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II from June 22-24, 2020 of Sutro Biopharma's folate receptor...

CytomX Therapeutics Acquires Technologies Developed by Agensys

Peter Hofland
Clinical-stage and oncology-focused biopharmaceutical company CytomX Therapeutics, pioneering a novel class of investigational antibody therapeutics based on its Probody™ therapeutic technology platform, has acquired...
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.

X